The lack of comparable developability data is a major bottleneck. Natural Antibody's CEO suggests a 'walk before you can run' approach: instead of accounting for all variables, the industry should create a foundational dataset under a single condition. This focused dataset has proven transferable predictive power.

Public datasets primarily show successful protein interactions, starving AI models of crucial "negative data"—plausible but incorrect interactions. A-Alpha Bio finds that providing this data on what fails is just as important for training predictive and generalizable models.

The cost to generate the volume of protein affinity data from a single multi-week A-AlphaBio experiment using standard methods like surface plasmon resonance (SPR) would be an economically unfeasible $100-$500 million. This staggering cost difference illustrates the fundamental barrier that new high-throughput platforms are designed to overcome.

The primary obstacle to leveraging AI in bioprocessing isn't developing advanced models, but solving the pre-existing, complex challenge of data readiness. Companies are still struggling to unify disparate data from different tools, sites, and GMP vs. development environments, turning intended "data lakes" into inaccessible "data swamps."

The bottleneck for AI in drug discovery is not the algorithm but the lack of high-quality, large-scale biological data. New platforms are needed to generate this necessary "substrate" for AI models to learn from, challenging the narrative that better models alone are the solution.

The primary bottleneck for creating powerful foundation models in biology is the lack of clean, large-scale experimental data—orders of magnitude less than what's available for LLMs. This creates a major opportunity for "data foundries" that use robotic labs to generate high-quality biological data at scale.

To break the data bottleneck in AI protein engineering, companies now generate massive synthetic datasets. By creating novel "synthetic epitopes" and measuring their binding, they can produce thousands of validated positive and negative training examples in a single experiment, massively accelerating model development.

Early AI models advanced by scraping web text and code. The next revolution, especially in "AI for science," requires overcoming a major hurdle: consolidating and formatting the world's vast but fragmented scientific data across disciplines like chemistry and materials science for model training.

The internet is an insufficient training ground for scientific AI because most crucial information—including failed experiments, negative data, and nuanced procedural details—is never published. This undocumented knowledge, what scientists call "good hands," represents a major data bottleneck for building truly intelligent scientific models.